메뉴 건너뛰기




Volumn 6, Issue SPEC.ISSUE.1, 2013, Pages 108-118

TRPV1 antagonists as analgesic agents

Author keywords

Capsaicin; Chronic pain; Hyperalgesia; Neuropathic pain; Resiniferatoxin; Small molecule TRPV1 antagonists; The capsaicin (vanilloid) receptor TRPV1; Transient receptor potential (TRP) channels

Indexed keywords

(5 TERT BUTYL 2,3 DIHYDRO 1H INDEN 1 YL) 3 (1H INDAZOL 4 YL)UREA; 1 (2 BROMOPHENYL) 3 [1 (5 TRIFLUOROMETHYL 2 PYRIDINYL) 3 PYRROLIDINYL]UREA; 1 (5 ISOQUINOLINYL) 3 [4 (TRIFLUOROMETHYL)BENZYL]UREA; 1 [2 (3,3 DIMETHYLBUTYL) 4 (TRIFLUOROMETHYL)BENZYL] 3 (1 METHYL 4 INDAZOLYL)UREA; 3 [2 (1 PIPERIDINYL) 6 (TRIFLUOROMETHYL) 3 PYRIDINYL] N (5,6,7,8 TETRAHYDRO 7 HYDROXY 1 NAPHTHYL)ACRYLAMIDE; 4 CHLORO N (3 METHOXYPHENYL)CINNAMAMIDE; A 784168; A 889425; A 995662; ABT 443; AMG 0610; AMG 628; AMG 6880; AMG 7472; AMG 8562; AS 1928370; AZD 1386; AZD 386; CAPSAZEPINE; DWP 05195; GRC 6211; JNJ 39729209; MK 2295; MR 1817; N (1,4 BENZODIOXAN 6 YL) 3 (4 TERT BUTYLPHENYL)ACRYLAMIDE; N [4 [6 [4 (TRIFLUOROMETHYL)PHENYL] 4 PYRIMIDINYLOXY]BENZOTHIAZOL 2 YL]ACETAMIDE; PHE 377; PHE 575; PLACEBO; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST;

EID: 84876070106     PISSN: None     EISSN: 18763863     Source Type: Journal    
DOI: 10.2174/1876386301306010108     Document Type: Review
Times cited : (32)

References (149)
  • 1
    • 84876092157 scopus 로고    scopus 로고
    • http://www.cnn.com/2008/health/conditions/04/28/pain.
  • 3
    • 33745607370 scopus 로고    scopus 로고
    • New and emerging treatment options for neuropathic pain
    • Gidal BE. New and emerging treatment options for neuropathic pain. Am J Manag Care 2006; 12(9 Suppl): S269-78.
    • (2006) Am J Manag Care , vol.12 , Issue.9 SUPPL.
    • Gidal, B.E.1
  • 4
    • 45949106393 scopus 로고    scopus 로고
    • Dilemmas in chronic/persistent pain management
    • Katz WA, Barkin RL. Dilemmas in chronic/persistent pain management. Am J Ther 2008; 15(3): 256-64.
    • (2008) Am J Ther , vol.15 , Issue.3 , pp. 256-264
    • Katz, W.A.1    Barkin, R.L.2
  • 5
    • 42149095966 scopus 로고    scopus 로고
    • Chronic pain and opiates: Balancing pain control and risks in long-term opioid treatment
    • Gallagher RM, Rosenthal LJ. Chronic pain and opiates: balancing pain control and risks in long-term opioid treatment. Arch Phys Med Rehabil 2008; 89(3 Suppl 1): S77-82.
    • (2008) Arch Phys Med Rehabil , vol.89 , Issue.3 SUPPL. 1
    • Gallagher, R.M.1    Rosenthal, L.J.2
  • 6
    • 84876070088 scopus 로고    scopus 로고
    • http://www.opiates.com/prescription-painkillers-addiction.html.
  • 7
    • 33744544769 scopus 로고    scopus 로고
    • Toward better pain control
    • Basbaum AI, Julius D. Toward better pain control. Sci Am 2006; 294(6): 60-7.
    • (2006) Sci Am , vol.294 , Issue.6 , pp. 60-67
    • Basbaum, A.I.1    Julius, D.2
  • 8
    • 33846149200 scopus 로고    scopus 로고
    • Transient receptor potential ion channels as participants in thermosensation and thermoregulation
    • Caterina MJ. Transient receptor potential ion channels as participants in thermosensation and thermoregulation. Am J Physiol Regul Integr Comp Physiol 2007; 292(1): R64-76.
    • (2007) Am J Physiol Regul Integr Comp Physiol , vol.292 , Issue.1
    • Caterina, M.J.1
  • 9
    • 0034926291 scopus 로고    scopus 로고
    • The vanilloid receptor: A molecular gateway to the pain pathway
    • Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001; 24: 487-517.
    • (2001) Annu Rev Neurosci , vol.24 , pp. 487-517
    • Caterina, M.J.1    Julius, D.2
  • 10
    • 2442660100 scopus 로고    scopus 로고
    • Molecular architecture of the vanilloid receptor. Insights for drug design
    • Ferrer-Montiel A, Garcia-Martinez C, Morenilla-Palao C, et al. Molecular architecture of the vanilloid receptor. Insights for drug design. Eur J Biochem 2004; 271(10): 1820-6.
    • (2004) Eur J Biochem , vol.271 , Issue.10 , pp. 1820-1826
    • Ferrer-Montiel, A.1    Garcia-Martinez, C.2    Morenilla-Palao, C.3
  • 11
    • 33847792875 scopus 로고    scopus 로고
    • The TRPV1 receptor and nociception
    • Immke DC, Gavva NR. The TRPV1 receptor and nociception. Semin Cell Dev Biol 2006; 17(5): 582-91.
    • (2006) Semin Cell Dev Biol , vol.17 , Issue.5 , pp. 582-591
    • Immke, D.C.1    Gavva, N.R.2
  • 13
    • 22944473968 scopus 로고    scopus 로고
    • Activation and activators of TRPV1 and their pharmaceutical implication
    • Suh YG, Oh U. Activation and activators of TRPV1 and their pharmaceutical implication. Curr Pharm Des 2005; 11(21): 2687-98.
    • (2005) Curr Pharm Des , vol.11 , Issue.21 , pp. 2687-2698
    • Suh, Y.G.1    Oh, U.2
  • 14
    • 16844367591 scopus 로고    scopus 로고
    • Pain TRPs
    • Wang H, Woolf CJ. Pain TRPs. Neuron 2005; 46(1): 9-12.
    • (2005) Neuron , vol.46 , Issue.1 , pp. 9-12
    • Wang, H.1    Woolf, C.J.2
  • 16
    • 0002294942 scopus 로고
    • Tincture of capsaicin as a remedy for chilblains and toothache
    • Turnbull A. Tincture of capsaicin as a remedy for chilblains and toothache. Dublin Free Press 1850; 1: 95-6.
    • (1850) Dublin Free Press , vol.1 , pp. 95-96
    • Turnbull, A.1
  • 17
    • 34447611041 scopus 로고
    • Beitrage zur physiologischen wirkung der bestandteile des Capsicum annum
    • Hogyes E. Beitrage zur physiologischen wirkung der bestandteile des Capsicum annum. Arch Exp Pathol Pharmakol 1878; 9: 117-30.
    • (1878) Arch Exp Pathol Pharmakol , vol.9 , pp. 117-130
    • Hogyes, E.1
  • 18
    • 0001926637 scopus 로고
    • Desensitization of sensory nerve endings
    • Jancso N, Jancso A. Desensitization of sensory nerve endings. Kísérletes Orvostudomány 1949; 2(2 (Suppl): 15.
    • (1949) Kísérletes Orvostudomány , vol.2 , Issue.2 SUPPL. , pp. 15
    • Jancso, N.1    Jancso, A.2
  • 19
    • 0014128266 scopus 로고
    • Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin
    • Jancso N, Jancso-Gabor A, Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother 1967; 31(1): 138-51.
    • (1967) Br J Pharmacol Chemother , vol.31 , Issue.1 , pp. 138-151
    • Jancso, N.1    Jancso-Gabor, A.2    Szolcsanyi, J.3
  • 20
    • 0017720392 scopus 로고
    • Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones
    • Jancso G, Kiraly E, Jancso-Gabor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature 1977; 270(5639): 741-3.
    • (1977) Nature , vol.270 , Issue.5639 , pp. 741-743
    • Jancso, G.1    Kiraly, E.2    Jancso-Gabor, A.3
  • 21
    • 0017640292 scopus 로고
    • A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain
    • Szolcsanyi J. A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. J Physiol (Paris) 1977; 73(3): 251-9.
    • (1977) J Physiol (Paris) , vol.73 , Issue.3 , pp. 251-259
    • Szolcsanyi, J.1
  • 22
    • 0024382437 scopus 로고
    • Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper
    • Szallasi A, Blumberg PM. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 1989; 30(2): 515-20.
    • (1989) Neuroscience , vol.30 , Issue.2 , pp. 515-520
    • Szallasi, A.1    Blumberg, P.M.2
  • 23
    • 0020432931 scopus 로고
    • Capsaicin-sensitive non-cholinergic excitatory innervation of the guinea-pig tracheobronchial smooth muscle
    • Szolcsanyi J, Bartho L. Capsaicin-sensitive non-cholinergic excitatory innervation of the guinea-pig tracheobronchial smooth muscle. Neurosci Lett 1982; 34(3): 247-51.
    • (1982) Neurosci Lett , vol.34 , Issue.3 , pp. 247-251
    • Szolcsanyi, J.1    Bartho, L.2
  • 24
    • 0023833519 scopus 로고
    • The sensory-efferent function of capsaicinsensitive sensory neurons
    • Maggi CA, Meli A. The sensory-efferent function of capsaicinsensitive sensory neurons. Gen Pharmacol 1988; 19(1): 1-43.
    • (1988) Gen Pharmacol , vol.19 , Issue.1 , pp. 1-43
    • Maggi, C.A.1    Meli, A.2
  • 25
    • 0025871477 scopus 로고
    • Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurons
    • Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991; 43(2): 143-201.
    • (1991) Pharmacol Rev , vol.43 , Issue.2 , pp. 143-201
    • Holzer, P.1
  • 26
    • 0032970173 scopus 로고    scopus 로고
    • Vanilloid (Capsaicin) receptors and mechanisms
    • Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999; 51(2): 159-212.
    • (1999) Pharmacol Rev , vol.51 , Issue.2 , pp. 159-212
    • Szallasi, A.1    Blumberg, P.M.2
  • 28
    • 0034646740 scopus 로고    scopus 로고
    • Impaired nociception and pain sensation in mice lacking the capsaicin receptor
    • Caterina MJ, Leffler A, Malmberg AB, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000; 288(5464): 306-13.
    • (2000) Science , vol.288 , Issue.5464 , pp. 306-313
    • Caterina, M.J.1    Leffler, A.2    Malmberg, A.B.3
  • 29
    • 0034636441 scopus 로고    scopus 로고
    • Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
    • Davis JB, Gray J, Gunthorpe MJ, et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000; 405(6783): 183-7.
    • (2000) Nature , vol.405 , Issue.6783 , pp. 183-187
    • Davis, J.B.1    Gray, J.2    Gunthorpe, M.J.3
  • 30
    • 33845343959 scopus 로고    scopus 로고
    • Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1
    • Christoph T, Gillen C, Mika J, et al. Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1. Neurochem Int 2007; 50(1): 281-90.
    • (2007) Neurochem Int , vol.50 , Issue.1 , pp. 281-290
    • Christoph, T.1    Gillen, C.2    Mika, J.3
  • 31
    • 33749050585 scopus 로고    scopus 로고
    • Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo
    • Christoph T, Grunweller A, Mika J, et al. Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo. Biochem Biophys Res Commun 2006; 350(1): 238-43.
    • (2006) Biochem Biophys Res Commun , vol.350 , Issue.1 , pp. 238-243
    • Christoph, T.1    Grunweller, A.2    Mika, J.3
  • 32
    • 34249990908 scopus 로고    scopus 로고
    • RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat
    • Kasama S, Kawakubo M, Suzuki T, Nishizawa T, Ishida A, Nakayama J. RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat. Eur J Neurosci 2007; 25(10): 2956-63.
    • (2007) Eur J Neurosci , vol.25 , Issue.10 , pp. 2956-2963
    • Kasama, S.1    Kawakubo, M.2    Suzuki, T.3    Nishizawa, T.4    Ishida, A.5    Nakayama, J.6
  • 33
    • 38549118896 scopus 로고    scopus 로고
    • Capsaicin (TRPV1 Agonist) therapy for pain relief: Farewell or revival?
    • Knotkova H, Pappagallo M, Szallasi A. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Clin J Pain 2008; 24(2): 142-54.
    • (2008) Clin J Pain , vol.24 , Issue.2 , pp. 142-154
    • Knotkova, H.1    Pappagallo, M.2    Szallasi, A.3
  • 35
    • 84876087274 scopus 로고    scopus 로고
    • Britain, British national formulary. BMA (No 45)
    • Britain. BMARPSoG. British national formulary. BMA 2003; (No 45).
    • (2003) BMARPSoG
  • 36
    • 84876075548 scopus 로고    scopus 로고
    • http://clinicaltrials.gov/ct2/show/NCT00804154?term=Resiniferatoxin& rank=1.
  • 37
    • 33846807748 scopus 로고    scopus 로고
    • Transient receptor potential cation channels in disease
    • Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 2007; 87(1): 165-217.
    • (2007) Physiol Rev , vol.87 , Issue.1 , pp. 165-217
    • Nilius, B.1    Owsianik, G.2    Voets, T.3    Peters, J.A.4
  • 40
    • 85047696992 scopus 로고    scopus 로고
    • Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1
    • Trevisani M, Smart D, Gunthorpe MJ, et al. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci 2002; 5(6): 546-51.
    • (2002) Nat Neurosci , vol.5 , Issue.6 , pp. 546-551
    • Trevisani, M.1    Smart, D.2    Gunthorpe, M.J.3
  • 41
    • 0043209362 scopus 로고    scopus 로고
    • ThermoTRP channels and beyond: Mechanisms of temperature sensation
    • Patapoutian A, Peier AM, Story GM, Viswanath V. ThermoTRP channels and beyond: mechanisms of temperature sensation. Nat Rev Neurosci 2003; 4(7): 529-39.
    • (2003) Nat Rev Neurosci , vol.4 , Issue.7 , pp. 529-539
    • Patapoutian, A.1    Peier, A.M.2    Story, G.M.3    Viswanath, V.4
  • 42
    • 33750873334 scopus 로고    scopus 로고
    • Spider toxins activate the capsaicin receptor to produce inflammatory pain
    • Siemens J, Zhou S, Piskorowski R, et al. Spider toxins activate the capsaicin receptor to produce inflammatory pain. Nature 2006; 444(7116): 208-12.
    • (2006) Nature , vol.444 , Issue.7116 , pp. 208-212
    • Siemens, J.1    Zhou, S.2    Piskorowski, R.3
  • 43
    • 34248138496 scopus 로고    scopus 로고
    • The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-ofconcept
    • Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-ofconcept. Nat Rev Drug Discov 2007; 6(5): 357-72.
    • (2007) Nat Rev Drug Discov , vol.6 , Issue.5 , pp. 357-372
    • Szallasi, A.1    Cortright, D.N.2    Blum, C.A.3    Eid, S.R.4
  • 44
    • 38349023182 scopus 로고    scopus 로고
    • Painful toxins acting at TRPV1
    • Cromer BA, McIntyre P. Painful toxins acting at TRPV1. Toxicon 2008; 51(2): 163-73.
    • (2008) Toxicon , vol.51 , Issue.2 , pp. 163-173
    • Cromer, B.A.1    McIntyre, P.2
  • 45
    • 33846913452 scopus 로고    scopus 로고
    • Capsaicin receptor: TRPV1 a promiscuous TRP channel
    • Pingle SC, Matta JA, Ahern GP. Capsaicin receptor: TRPV1 a promiscuous TRP channel. Handb Exp Pharmacol 2007; 179: 155-71.
    • (2007) Handb Exp Pharmacol , vol.179 , pp. 155-171
    • Pingle, S.C.1    Matta, J.A.2    Ahern, G.P.3
  • 46
    • 77956130879 scopus 로고    scopus 로고
    • Activation of the human transient receptor potential vanilloid subtype 1 by essential oils
    • Ohkawara S, Tanaka-Kagawa T, Furukawa Y, Nishimura T, Jinno H. Activation of the human transient receptor potential vanilloid subtype 1 by essential oils. Biol Pharm Bull 2010; 33(8): 1434-7.
    • (2010) Biol Pharm Bull , vol.33 , Issue.8 , pp. 1434-1437
    • Ohkawara, S.1    Tanaka-Kagawa, T.2    Furukawa, Y.3    Nishimura, T.4    Jinno, H.5
  • 47
    • 77953531871 scopus 로고    scopus 로고
    • The deorphanization of TRPV1 and the emergence of octadecadienoids as a new class of lipid transmitters
    • Flores CM, Vasko MR. The deorphanization of TRPV1 and the emergence of octadecadienoids as a new class of lipid transmitters. Mol Interv 2010; 10(3): 137-40.
    • (2010) Mol Interv , vol.10 , Issue.3 , pp. 137-140
    • Flores, C.M.1    Vasko, M.R.2
  • 48
    • 77953271751 scopus 로고    scopus 로고
    • A bivalent tarantula toxin activates the capsaicin receptor, TRPV1, by targeting the outer pore domain
    • Bohlen CJ, Priel A, Zhou S, King D, Siemens J, Julius D. A bivalent tarantula toxin activates the capsaicin receptor, TRPV1, by targeting the outer pore domain. Cell 2010; 141(5): 834-45.
    • (2010) Cell , vol.141 , Issue.5 , pp. 834-845
    • Bohlen, C.J.1    Priel, A.2    Zhou, S.3    King, D.4    Siemens, J.5    Julius, D.6
  • 49
    • 77951787575 scopus 로고    scopus 로고
    • Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents
    • Patwardhan AM, Akopian AN, Ruparel NB, et al. Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents. J Clin Invest 2010; 120(5): 1617-26.
    • (2010) J Clin Invest , vol.120 , Issue.5 , pp. 1617-1626
    • Patwardhan, A.M.1    Akopian, A.N.2    Ruparel, N.B.3
  • 50
    • 77956513789 scopus 로고    scopus 로고
    • Tumor necrosis factor alpha sensitizes spinal cord TRPV1 receptors to the endogenous agonist Noleoyldopamine
    • Spicarova D, Palecek J. Tumor necrosis factor alpha sensitizes spinal cord TRPV1 receptors to the endogenous agonist Noleoyldopamine. J Neuroinflammation 2010; 7: 49.
    • (2010) J Neuroinflammation , vol.7 , pp. 49
    • Spicarova, D.1    Palecek, J.2
  • 51
    • 0035425705 scopus 로고    scopus 로고
    • Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide
    • Vellani V, Mapplebeck S, Moriondo A, Davis JB, McNaughton PA. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J Physiol 2001; 534(Pt 3): 813-25.
    • (2001) J Physiol , vol.534 , Issue.PART 3 , pp. 813-825
    • Vellani, V.1    Mapplebeck, S.2    Moriondo, A.3    Davis, J.B.4    McNaughton, P.A.5
  • 52
    • 2342604388 scopus 로고    scopus 로고
    • Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia
    • Amadesi S, Nie J, Vergnolle N, et al. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 2004; 24(18): 4300-12.
    • (2004) J Neurosci , vol.24 , Issue.18 , pp. 4300-4312
    • Amadesi, S.1    Nie, J.2    Vergnolle, N.3
  • 53
    • 77957118845 scopus 로고    scopus 로고
    • Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones
    • Vellani V, Kinsey AM, Prandini M, et al. Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones. Mol Pain 2010; 6(1): 61.
    • (2010) Mol Pain , vol.6 , Issue.1 , pp. 61
    • Vellani, V.1    Kinsey, A.M.2    Prandini, M.3
  • 54
    • 0036535063 scopus 로고    scopus 로고
    • The diversity in the vanilloid (TRPV) receptor family of ion channels
    • Gunthorpe MJ, Benham CD, Randall A, Davis JB. The diversity in the vanilloid (TRPV) receptor family of ion channels. Trends Pharmacol Sci 2002; 23(4): 183-91.
    • (2002) Trends Pharmacol Sci , vol.23 , Issue.4 , pp. 183-191
    • Gunthorpe, M.J.1    Benham, C.D.2    Randall, A.3    Davis, J.B.4
  • 55
    • 0036291431 scopus 로고    scopus 로고
    • Activation of protein kinase C sensitizes human VR1 to capsaicin and to moderate decreases in pH at physiological temperatures in Xenopus oocytes
    • Crandall M, Kwash J, Yu W, White G. Activation of protein kinase C sensitizes human VR1 to capsaicin and to moderate decreases in pH at physiological temperatures in Xenopus oocytes. Pain 2002; 98(1-2): 109-17.
    • (2002) Pain , vol.98 , Issue.1-2 , pp. 109-117
    • Crandall, M.1    Kwash, J.2    Yu, W.3    White, G.4
  • 56
    • 78049367698 scopus 로고    scopus 로고
    • The general anesthetic propofol excites nociceptors by activating Trpv1 and Trpa1 rather than Gabaa receptors
    • Fischer MJ, Leffler A, Niedermirtl F, et al. The general anesthetic propofol excites nociceptors by activating Trpv1 and Trpa1 rather than Gabaa receptors. J Biol Chem 2010; 285(45): 34781-92.
    • (2010) J Biol Chem , vol.285 , Issue.45 , pp. 34781-34792
    • Fischer, M.J.1    Leffler, A.2    Niedermirtl, F.3
  • 57
    • 0034589732 scopus 로고    scopus 로고
    • Nociceptor excitation by thermal sensitization--a hypothesis
    • Reeh PW, Petho G. Nociceptor excitation by thermal sensitization--a hypothesis. Prog Brain Res 2000; 129: 39-50.
    • (2000) Prog Brain Res , vol.129 , pp. 39-50
    • Reeh, P.W.1    Petho, G.2
  • 58
    • 0034700494 scopus 로고    scopus 로고
    • Induction of vanilloid receptor channel activity by protein kinase C
    • Premkumar LS, Ahern GP. Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000; 408(6815): 985-90.
    • (2000) Nature , vol.408 , Issue.6815 , pp. 985-990
    • Premkumar, L.S.1    Ahern, G.P.2
  • 59
    • 0035810934 scopus 로고    scopus 로고
    • Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia
    • Tominaga M, Wada M, Masu M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci U S A 2001; 98(12): 6951-6.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , Issue.12 , pp. 6951-6956
    • Tominaga, M.1    Wada, M.2    Masu, M.3
  • 60
    • 0036729532 scopus 로고    scopus 로고
    • Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve
    • Kagaya M, Lamb J, Robbins J, Page CP, Spina D. Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. Br J Pharmacol 2002; 137(1): 39-48.
    • (2002) Br J Pharmacol , vol.137 , Issue.1 , pp. 39-48
    • Kagaya, M.1    Lamb, J.2    Robbins, J.3    Page, C.P.4    Spina, D.5
  • 61
    • 0037144453 scopus 로고    scopus 로고
    • Protein kinase C(alpha) is required for vanilloid receptor 1 activation. Evidence for multiple signaling pathways
    • Olah Z, Karai L, Iadarola MJ. Protein kinase C(alpha) is required for vanilloid receptor 1 activation. Evidence for multiple signaling pathways. J Biol Chem 2002; 277(38): 35752-9.
    • (2002) J Biol Chem , vol.277 , Issue.38 , pp. 35752-35759
    • Olah, Z.1    Karai, L.2    Iadarola, M.J.3
  • 62
    • 0142059776 scopus 로고    scopus 로고
    • Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1)
    • Bhave G, Hu HJ, Glauner KS, et al. Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc Natl Acad Sci U S A 2003; 100(21): 12480-5.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , Issue.21 , pp. 12480-12485
    • Bhave, G.1    Hu, H.J.2    Glauner, K.S.3
  • 63
    • 33646498289 scopus 로고    scopus 로고
    • Relative roles of protein kinase A and protein kinase C in modulation of transient receptor potential vanilloid type 1 receptor responsiveness in rat sensory neurons in vitro and peripheral nociceptors in vivo
    • Varga A, Bolcskei K, Szoke E, et al. Relative roles of protein kinase A and protein kinase C in modulation of transient receptor potential vanilloid type 1 receptor responsiveness in rat sensory neurons in vitro and peripheral nociceptors in vivo. Neuroscience 2006; 140(2): 645-57.
    • (2006) Neuroscience , vol.140 , Issue.2 , pp. 645-657
    • Varga, A.1    Bolcskei, K.2    Szoke, E.3
  • 64
    • 33748180653 scopus 로고    scopus 로고
    • The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway
    • Vetter I, Wyse BD, Monteith GR, Roberts-Thomson SJ, Cabot PJ. The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway. Mol Pain 2006; 2: 22.
    • (2006) Mol Pain , vol.2 , pp. 22
    • Vetter, I.1    Wyse, B.D.2    Monteith, G.R.3    Roberts-Thomson, S.J.4    Cabot, P.J.5
  • 65
    • 33750510073 scopus 로고    scopus 로고
    • Why pain gets worse: The mechanism of heat hyperalgesia
    • Zhang X, McNaughton PA. Why pain gets worse: the mechanism of heat hyperalgesia. J Gen Physiol 2006; 128(5): 491-3.
    • (2006) J Gen Physiol , vol.128 , Issue.5 , pp. 491-493
    • Zhang, X.1    McNaughton, P.A.2
  • 66
    • 0037799198 scopus 로고    scopus 로고
    • A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity
    • Prescott ED, Julius D. A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity. Science 2003; 300(5623): 1284-8.
    • (2003) Science , vol.300 , Issue.5623 , pp. 1284-1288
    • Prescott, E.D.1    Julius, D.2
  • 67
    • 34547200183 scopus 로고    scopus 로고
    • Dissection of the components for PIP2 activation and thermosensation in TRP channels
    • Brauchi S, Orta G, Mascayano C, et al. Dissection of the components for PIP2 activation and thermosensation in TRP channels. Proc Natl Acad Sci U S A 2007; 104(24): 10246-51.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , Issue.24 , pp. 10246-10251
    • Brauchi, S.1    Orta, G.2    Mascayano, C.3
  • 68
    • 34250190946 scopus 로고    scopus 로고
    • The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity
    • Lishko PV, Procko E, Jin X, Phelps CB, Gaudet R. The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. Neuron 2007; 54(6): 905-18.
    • (2007) Neuron , vol.54 , Issue.6 , pp. 905-918
    • Lishko, P.V.1    Procko, E.2    Jin, X.3    Phelps, C.B.4    Gaudet, R.5
  • 69
    • 33750524257 scopus 로고    scopus 로고
    • Phosphoinositide 3-kinase binds to TRPV1 and mediates NGFstimulated TRPV1 trafficking to the plasma membrane
    • Stein AT, Ufret-Vincenty CA, Hua L, Santana LF, Gordon SE. Phosphoinositide 3-kinase binds to TRPV1 and mediates NGFstimulated TRPV1 trafficking to the plasma membrane. J Gen Physiol 2006; 128(5): 509-22.
    • (2006) J Gen Physiol , vol.128 , Issue.5 , pp. 509-522
    • Stein, A.T.1    Ufret-Vincenty, C.A.2    Hua, L.3    Santana, L.F.4    Gordon, S.E.5
  • 71
    • 17144397173 scopus 로고    scopus 로고
    • Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMPdependent protein kinase
    • Mohapatra DP, Nau C. Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMPdependent protein kinase. J Biol Chem 2005; 280(14): 13424-32.
    • (2005) J Biol Chem , vol.280 , Issue.14 , pp. 13424-13432
    • Mohapatra, D.P.1    Nau, C.2
  • 72
    • 0037104657 scopus 로고    scopus 로고
    • cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation
    • Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RWt. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 2002; 35(4): 721-31.
    • (2002) Neuron , vol.35 , Issue.4 , pp. 721-731
    • Bhave, G.1    Zhu, W.2    Wang, H.3    Brasier, D.J.4    Oxford, G.S.5    Gereau, R.W.6
  • 73
    • 0346118925 scopus 로고    scopus 로고
    • Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway
    • Mohapatra DP, Nau C. Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway. J Biol Chem 2003; 278(50): 50080-90.
    • (2003) J Biol Chem , vol.278 , Issue.50 , pp. 50080-50090
    • Mohapatra, D.P.1    Nau, C.2
  • 76
    • 1342346561 scopus 로고    scopus 로고
    • Phosphorylation of vanilloid receptor 1 by Ca2+/calmodulin-dependent kinase II regulates its vanilloid binding
    • Jung J, Shin JS, Lee SY, et al. Phosphorylation of vanilloid receptor 1 by Ca2+/calmodulin-dependent kinase II regulates its vanilloid binding. J Biol Chem 2004; 279(8): 7048-54.
    • (2004) J Biol Chem , vol.279 , Issue.8 , pp. 7048-7054
    • Jung, J.1    Shin, J.S.2    Lee, S.Y.3
  • 78
    • 39449102203 scopus 로고    scopus 로고
    • Peripheral TRPV1 receptors as targets for drug development: New molecules and mechanisms
    • Gunthorpe MJ, Szallasi A. Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms. Curr Pharm Des 2008; 14(1): 32-41.
    • (2008) Curr Pharm Des , vol.14 , Issue.1 , pp. 32-41
    • Gunthorpe, M.J.1    Szallasi, A.2
  • 79
    • 34250202592 scopus 로고    scopus 로고
    • TRPV1 antagonists as a potential treatment for hyperalgesia
    • Roberts LA, Connor M. TRPV1 antagonists as a potential treatment for hyperalgesia. Recent Pat CNS Drug Discov 2006; 1(1): 65-76.
    • (2006) Recent Pat CNS Drug Discov , vol.1 , Issue.1 , pp. 65-76
    • Roberts, L.A.1    Connor, M.2
  • 80
    • 40749097682 scopus 로고    scopus 로고
    • Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists
    • Gharat L, Szallasi A. Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists. Expert Opin Thera Pat 2008; 18: 159-209.
    • (2008) Expert Opin Thera Pat , vol.18 , pp. 159-209
    • Gharat, L.1    Szallasi, A.2
  • 81
    • 34848820269 scopus 로고    scopus 로고
    • The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans
    • Chizh BA, O'Donnell MB, Napolitano A, et al. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain 2007; 132(1-2): 132-41.
    • (2007) Pain , vol.132 , Issue.1-2 , pp. 132-141
    • Chizh, B.A.1    O'Donnell, M.B.2    Napolitano, A.3
  • 83
    • 84876093293 scopus 로고    scopus 로고
    • http://www.pharmeste.com/home.asp?op=interna&id=2&id_pag=-10&tit=Pipeline.
  • 84
    • 84876075007 scopus 로고    scopus 로고
    • http://www.daewoong.co.kr/www_pharm/english_new/products/-pipeline.asp.
  • 85
    • 84876079017 scopus 로고    scopus 로고
    • http://clinicaltrials.gov/ct2/show/NCT00960180.
  • 86
    • 84876097564 scopus 로고    scopus 로고
    • http://www.gsk.com/investors/product_pipeline/docs/GSKproduct-pipeline-Feb-2012.pdf.
  • 87
    • 0026767602 scopus 로고
    • Capsazepine: A competitive antagonist of the sensory neurone excitant capsaicin
    • Bevan S, Hothi S, Hughes G, et al. Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br J Pharmacol 1992; 107(2): 544-52.
    • (1992) Br J Pharmacol , vol.107 , Issue.2 , pp. 544-552
    • Bevan, S.1    Hothi, S.2    Hughes, G.3
  • 88
    • 23044500197 scopus 로고    scopus 로고
    • Conservation of functional and pharmacological properties in the distantly related temperature sensors TRVP1 and TRPM8
    • Weil A, Moore SE, Waite NJ, Randall A, Gunthorpe MJ. Conservation of functional and pharmacological properties in the distantly related temperature sensors TRVP1 and TRPM8. Mol Pharmacol 2005; 68(2): 518-27.
    • (2005) Mol Pharmacol , vol.68 , Issue.2 , pp. 518-527
    • Weil, A.1    Moore, S.E.2    Waite, N.J.3    Randall, A.4    Gunthorpe, M.J.5
  • 89
    • 37249065119 scopus 로고    scopus 로고
    • TRPM8 mechanism of cold allodynia after chronic nerve injury
    • Xing H, Chen M, Ling J, Tan W, Gu JG. TRPM8 mechanism of cold allodynia after chronic nerve injury. J Neurosci 2007; 27(50): 13680-90.
    • (2007) J Neurosci , vol.27 , Issue.50 , pp. 13680-13690
    • Xing, H.1    Chen, M.2    Ling, J.3    Tan, W.4    Gu, J.G.5
  • 90
    • 0037215646 scopus 로고    scopus 로고
    • The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain
    • Walker KM, Urban L, Medhurst SJ, et al. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 2003; 304(1): 56-62.
    • (2003) J Pharmacol Exp Ther , vol.304 , Issue.1 , pp. 56-62
    • Walker, K.M.1    Urban, L.2    Medhurst, S.J.3
  • 91
    • 84155175206 scopus 로고    scopus 로고
    • The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor
    • Holzer P. The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor. Br J Pharmacol 2008; 22: 22.
    • (2008) Br J Pharmacol , vol.22 , pp. 22
    • Holzer, P.1
  • 92
    • 27844465429 scopus 로고    scopus 로고
    • Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1
    • Gavva NR, Tamir R, Klionsky L, et al. Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1. Mol Pharmacol 2005; 68(6): 1524-33.
    • (2005) Mol Pharmacol , vol.68 , Issue.6 , pp. 1524-1533
    • Gavva, N.R.1    Tamir, R.2    Klionsky, L.3
  • 93
    • 45749092572 scopus 로고    scopus 로고
    • Antihyperalgesic effects of (R, E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluorom ethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats
    • Lehto SG, Tamir R, Deng H, et al. Antihyperalgesic effects of (R, E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluorom ethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats. J Pharmacol Exp Ther 2008; 326(1): 218-29.
    • (2008) J Pharmacol Exp Ther , vol.326 , Issue.1 , pp. 218-229
    • Lehto, S.G.1    Tamir, R.2    Deng, H.3
  • 94
    • 0036894895 scopus 로고    scopus 로고
    • Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin
    • Seabrook GR, Sutton KG, Jarolimek W, et al. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin. J Pharmacol Exp Ther 2002; 303(3): 1052-60.
    • (2002) J Pharmacol Exp Ther , vol.303 , Issue.3 , pp. 1052-1060
    • Seabrook, G.R.1    Sutton, K.G.2    Jarolimek, W.3
  • 95
    • 2442498381 scopus 로고    scopus 로고
    • Molecular determinants of vanilloid sensitivity in TRPV1
    • Gavva NR, Klionsky L, Qu Y, et al. Molecular determinants of vanilloid sensitivity in TRPV1. J Biol Chem 2004; 279(19): 20283-95.
    • (2004) J Biol Chem , vol.279 , Issue.19 , pp. 20283-20295
    • Gavva, N.R.1    Klionsky, L.2    Qu, Y.3
  • 97
    • 84876072265 scopus 로고    scopus 로고
    • http://www.glenmarkpharma.com/media/pdf/releases/GRC_6211. pdf.
  • 98
    • 84876089995 scopus 로고    scopus 로고
    • http://www.glenmarkpharma.com/research/clinical.html.
  • 99
    • 0038128285 scopus 로고    scopus 로고
    • N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetr-ahydropyrazine-1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. In: Vivo characterization in rat models of inflammatory and neuropathic pain
    • Pomonis JD, Harrison JE, Mark L, Bristol DR, Valenzano KJ, Walker K. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetr-ahydropyrazine-1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. In: vivo characterization in rat models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 2003; 306(1): 387-93.
    • (2003) J Pharmacol Exp Ther , vol.306 , Issue.1 , pp. 387-393
    • Pomonis, J.D.1    Harrison, J.E.2    Mark, L.3    Bristol, D.R.4    Valenzano, K.J.5    Walker, K.6
  • 100
    • 43949109903 scopus 로고    scopus 로고
    • Characterization of primary sensory neurons mediating static and dynamic allodynia in rat chronic constriction injury model
    • Yamamoto W, Sugiura A, Nakazato-Imasato E, Kita Y. Characterization of primary sensory neurons mediating static and dynamic allodynia in rat chronic constriction injury model. J Pharm Pharmacol 2008; 60(6): 717-22.
    • (2008) J Pharm Pharmacol , vol.60 , Issue.6 , pp. 717-722
    • Yamamoto, W.1    Sugiura, A.2    Nakazato-Imasato, E.3    Kita, Y.4
  • 101
    • 20144376596 scopus 로고    scopus 로고
    • Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist
    • Swanson DM, Dubin AE, Shah C, et al. Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist. J Med Chem 2005; 48(6): 1857-72.
    • (2005) J Med Chem , vol.48 , Issue.6 , pp. 1857-1872
    • Swanson, D.M.1    Dubin, A.E.2    Shah, C.3
  • 103
    • 33748680717 scopus 로고    scopus 로고
    • TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists
    • Cui M, Honore P, Zhong C, et al. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci 2006; 26(37): 9385-93.
    • (2006) J Neurosci , vol.26 , Issue.37 , pp. 9385-9393
    • Cui, M.1    Honore, P.2    Zhong, C.3
  • 104
    • 79951977972 scopus 로고    scopus 로고
    • Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect
    • Watabiki T, Kiso T, Kuramochi T, et al. Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect. J Pharmacol Exp Ther 2011; 336(3): 743-50.
    • (2011) J Pharmacol Exp Ther , vol.336 , Issue.3 , pp. 743-750
    • Watabiki, T.1    Kiso, T.2    Kuramochi, T.3
  • 105
    • 84876091239 scopus 로고    scopus 로고
    • http://www.acsmedchem.org/mediabstracts2011.pdf.
  • 106
    • 84855293744 scopus 로고    scopus 로고
    • TRPV1 antagonist, A-889425, inhibits mechanotransmission in a subclass of rat primary afferent neurons following peripheral inflammation
    • Brederson JD, Chu KL, Reilly RM, et al. TRPV1 antagonist, A-889425, inhibits mechanotransmission in a subclass of rat primary afferent neurons following peripheral inflammation. Synapse 2011; 66(3): 187-95.
    • (2011) Synapse , vol.66 , Issue.3 , pp. 187-195
    • Brederson, J.D.1    Chu, K.L.2    Reilly, R.M.3
  • 107
    • 23044496253 scopus 로고    scopus 로고
    • A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats
    • Honore P, Wismer CT, Mikusa J, et al. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J Pharmacol Exp Ther 2005; 314(1): 410-21.
    • (2005) J Pharmacol Exp Ther , vol.314 , Issue.1 , pp. 410-421
    • Honore, P.1    Wismer, C.T.2    Mikusa, J.3
  • 109
    • 84876096851 scopus 로고    scopus 로고
    • http://clinicaltrials.gov/ct2/results?term=ABT-102.
  • 110
    • 53849138741 scopus 로고    scopus 로고
    • (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo
    • Surowy CS, Neelands TR, Bianchi BR, et al. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo. J Pharmacol Exp Ther 2008; 326(3): 879-88.
    • (2008) J Pharmacol Exp Ther , vol.326 , Issue.3 , pp. 879-888
    • Surowy, C.S.1    Neelands, T.R.2    Bianchi, B.R.3
  • 111
    • 39149117718 scopus 로고    scopus 로고
    • Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management
    • Gomtsyan A, Bayburt EK, Schmidt RG, et al. Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management. J Med Chem 2008; 51(3): 392-5.
    • (2008) J Med Chem , vol.51 , Issue.3 , pp. 392-395
    • Gomtsyan, A.1    Bayburt, E.K.2    Schmidt, R.G.3
  • 112
    • 77953285275 scopus 로고    scopus 로고
    • Discovery of TRPV1 antagonist ABT-116
    • Brown BS, Keddy R, Perner RJ, et al. Discovery of TRPV1 antagonist ABT-116. Bioorg Med Chem Lett 2010; 20(11): 3291-4.
    • (2010) Bioorg Med Chem Lett , vol.20 , Issue.11 , pp. 3291-3294
    • Brown, B.S.1    Keddy, R.2    Perner, R.J.3
  • 113
    • 77955304164 scopus 로고    scopus 로고
    • A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydr onaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model
    • Puttfarcken PS, Han P, Joshi SK, et al. A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydr onaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model. Pain 2010; 150(2): 319-26.
    • (2010) Pain , vol.150 , Issue.2 , pp. 319-326
    • Puttfarcken, P.S.1    Han, P.2    Joshi, S.K.3
  • 114
    • 79959289728 scopus 로고    scopus 로고
    • Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist
    • Maher MP, Bhattacharya A, Ao H, et al. Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist. Eur J Pharmacol 2011; 663(1-3): 40-50.
    • (2011) Eur J Pharmacol , vol.663 , Issue.1-3 , pp. 40-50
    • Maher, M.P.1    Bhattacharya, A.2    Ao, H.3
  • 115
    • 79960306015 scopus 로고    scopus 로고
    • Intrathecal administration of AS1928370, a transient receptor potential vanilloid 1 antagonist, attenuates mechanical allodynia in a mouse model of neuropathic pain
    • Watabiki T, Kiso T, Tsukamoto M, Aoki T, Matsuoka N. Intrathecal administration of AS1928370, a transient receptor potential vanilloid 1 antagonist, attenuates mechanical allodynia in a mouse model of neuropathic pain. Biol Pharm Bull 2011; 34(7): 1105-8.
    • (2011) Biol Pharm Bull , vol.34 , Issue.7 , pp. 1105-1108
    • Watabiki, T.1    Kiso, T.2    Tsukamoto, M.3    Aoki, T.4    Matsuoka, N.5
  • 116
    • 33750611879 scopus 로고    scopus 로고
    • Ziconotide: A new nonopioid intrathecal analgesic for the treatment of chronic pain
    • Wallace MS. Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain. Expert Rev Neurother 2006; 6(10): 1423-8.
    • (2006) Expert Rev Neurother , vol.6 , Issue.10 , pp. 1423-1428
    • Wallace, M.S.1
  • 118
    • 27644551317 scopus 로고    scopus 로고
    • Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model
    • Brown DC, Iadarola MJ, Perkowski SZ, et al. Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model. Anesthesiology 2005; 103(5): 1052-9.
    • (2005) Anesthesiology , vol.103 , Issue.5 , pp. 1052-1059
    • Brown, D.C.1    Iadarola, M.J.2    Perkowski, S.Z.3
  • 119
    • 0021737076 scopus 로고
    • Capsaicin and central control of thermoregulation
    • Hori T. Capsaicin and central control of thermoregulation. Pharmacol Ther 1984; 26(3): 389-416.
    • (1984) Pharmacol Ther , vol.26 , Issue.3 , pp. 389-416
    • Hori, T.1
  • 121
    • 34047118624 scopus 로고    scopus 로고
    • The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation
    • Gavva NR, Bannon AW, Surapaneni S, et al. The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J Neurosci 2007; 27(13): 3366-74.
    • (2007) J Neurosci , vol.27 , Issue.13 , pp. 3366-3374
    • Gavva, N.R.1    Bannon, A.W.2    Surapaneni, S.3
  • 122
    • 70349659983 scopus 로고    scopus 로고
    • The transient receptor potential vanilloid-1 channel in thermoregulation: A thermosensor it is not
    • Romanovsky AA, Almeida MC, Garami A, et al. The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not. Pharmacol Rev 2009; 61(3): 228-61.
    • (2009) Pharmacol Rev , vol.61 , Issue.3 , pp. 228-261
    • Romanovsky, A.A.1    Almeida, M.C.2    Garami, A.3
  • 123
    • 67649240813 scopus 로고    scopus 로고
    • Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1
    • Gavva NR. Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends Pharmacol Sci 2008; 19: 19.
    • (2008) Trends Pharmacol Sci , vol.19 , pp. 19
    • Gavva, N.R.1
  • 124
    • 41749117999 scopus 로고    scopus 로고
    • Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans
    • Gavva NR, Treanor JJ, Garami A, et al. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 2008; 136(1-2): 202-10.
    • (2008) Pain , vol.136 , Issue.1-2 , pp. 202-210
    • Gavva, N.R.1    Treanor, J.J.2    Garami, A.3
  • 125
    • 34447504896 scopus 로고    scopus 로고
    • Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors
    • Steiner AA, Turek VF, Almeida MC, et al. Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors. J Neurosci 2007; 27(28): 7459-68.
    • (2007) J Neurosci , vol.27 , Issue.28 , pp. 7459-7468
    • Steiner, A.A.1    Turek, V.F.2    Almeida, M.C.3
  • 126
    • 34548825160 scopus 로고    scopus 로고
    • Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade
    • Gavva NR, Bannon AW, Hovland DN, et al. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade. J Pharmacol Exp Ther 2007; 323(1): 128-37.
    • (2007) J Pharmacol Exp Ther , vol.323 , Issue.1 , pp. 128-137
    • Gavva, N.R.1    Bannon, A.W.2    Hovland, D.N.3
  • 127
    • 84872430052 scopus 로고    scopus 로고
    • Novel TRPV1 receptor antagonists that partially block acid activation. In vitro pharmacology predicts effects on core body temperature and in vivo efficacy
    • In Press
    • Reilly R, McDonald H, Puttfarcken P, et al. Novel TRPV1 receptor antagonists that partially block acid activation. In vitro pharmacology predicts effects on core body temperature and in vivo efficacy. J Pharmacol Exp Ther 2012; In Press.
    • (2012) J Pharmacol Exp Ther
    • Reilly, R.1    McDonald, H.2    Puttfarcken, P.3
  • 128
    • 84864142720 scopus 로고    scopus 로고
    • BCTP, a classic polymodal inhibitor of TRPV1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity
    • Nash MS, McIntyre P, Groarke A, et al. BCTP, a classic polymodal inhibitor of TRPV1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity. J Pharmacol Exp Ther 2012; 342(2): 389-98.
    • (2012) J Pharmacol Exp Ther , vol.342 , Issue.2 , pp. 389-398
    • Nash, M.S.1    McIntyre, P.2    Groarke, A.3
  • 129
    • 0037133281 scopus 로고    scopus 로고
    • Attenuation of thermal nociception and hyperalgesia by VR1 blockers
    • Garcia-Martinez C, Humet M, Planells-Cases R, et al. Attenuation of thermal nociception and hyperalgesia by VR1 blockers. Proc Natl Acad Sci U S A 2002; 99(4): 2374-9.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , Issue.4 , pp. 2374-2379
    • Garcia-Martinez, C.1    Humet, M.2    Planells-Cases, R.3
  • 130
    • 34247281575 scopus 로고    scopus 로고
    • Antinociceptive pharmacology of N-(4-chlorobenzyl)-N'-(4-hydroxy-3-iodo-5-methoxybenzyl) thiourea, a high-affinity competitive antagonist of the transient receptor potential vanilloid 1 receptor
    • Tang L, Chen Y, Chen Z, Blumberg PM, Kozikowski AP, Wang ZJ. Antinociceptive pharmacology of N-(4-chlorobenzyl)-N'-(4-hydroxy-3-iodo-5-methoxybenzyl) thiourea, a high-affinity competitive antagonist of the transient receptor potential vanilloid 1 receptor. J Pharmacol Exp Ther 2007; 321(2): 791-8.
    • (2007) J Pharmacol Exp Ther , vol.321 , Issue.2 , pp. 791-798
    • Tang, L.1    Chen, Y.2    Chen, Z.3    Blumberg, P.M.4    Kozikowski, A.P.5    Wang, Z.J.6
  • 132
    • 70349335960 scopus 로고    scopus 로고
    • Use of sensory methods for detecting target engagement in clinical trials of new analgesics
    • Chizh BA, Sang CN. Use of sensory methods for detecting target engagement in clinical trials of new analgesics. Neurotherapeutics 2009; 6(4): 749-54.
    • (2009) Neurotherapeutics , vol.6 , Issue.4 , pp. 749-754
    • Chizh, B.A.1    Sang, C.N.2
  • 134
    • 84863187892 scopus 로고    scopus 로고
    • Pharmacokinetics of the TRPV1 antagonist ABT-102 in healthy human volunteers: Population analysis of data from 3 phase 1 trials
    • Othman AA, Nothaft W, Awni WM, Dutta S. Pharmacokinetics of the TRPV1 antagonist ABT-102 in healthy human volunteers: population analysis of data from 3 phase 1 trials. J Clin Pharmacol 2012; 52(7): 1028-41.
    • (2012) J Clin Pharmacol , vol.52 , Issue.7 , pp. 1028-1041
    • Othman, A.A.1    Nothaft, W.2    Awni, W.M.3    Dutta, S.4
  • 135
    • 79954584227 scopus 로고    scopus 로고
    • Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial
    • Rowbotham MC, Nothaft W, Duan WR, et al. Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial. Pain 2011; 152(5): 1192-200.
    • (2011) Pain , vol.152 , Issue.5 , pp. 1192-1200
    • Rowbotham, M.C.1    Nothaft, W.2    Duan, W.R.3
  • 136
    • 84876085694 scopus 로고    scopus 로고
    • http://clinicaltrials.gov/ct2/show/NCT00969787?term=05195&rank= 1.
  • 137
    • 84876075329 scopus 로고    scopus 로고
    • http://www.pharmeste.com/include/PHE377.pdf.
  • 138
    • 84876084696 scopus 로고    scopus 로고
    • http://clinicaltrials.gov/ct2/show/NCT00281684?cond.
  • 139
    • 84876097746 scopus 로고    scopus 로고
    • http://clinicaltrials.gov/ct2/show/NCT01424514?term=705498&-rank=1.
  • 140
    • 84876084267 scopus 로고    scopus 로고
    • http://clinicaltrials.gov/ct2/show/NCT01476098?term=705498&-rank=4.
  • 141
    • 79954617292 scopus 로고    scopus 로고
    • Randomised clinical trial: The efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain
    • Krarup AL, Ny L, Astrand M, et al. Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain. Aliment Pharmacol Ther 2011; 33(10): 1113-22.
    • (2011) Aliment Pharmacol Ther , vol.33 , Issue.10 , pp. 1113-1122
    • Krarup, A.L.1    Ny, L.2    Astrand, M.3
  • 142
    • 84876088959 scopus 로고    scopus 로고
    • http://www.astrazenecaclinicaltrials.com/other-drug-products/discontinued-products/AZD1386/?expandAll=true.
  • 143
    • 84876087895 scopus 로고    scopus 로고
    • http://www.astrazenecaclinicaltrials.com/_mshost800325/content/clinical-trials/resources/pdf/D5090C00019.
  • 144
    • 84876092464 scopus 로고    scopus 로고
    • http://www.glenmarkpharma.cz/gln3.php?lang=en.
  • 145
    • 84876081793 scopus 로고    scopus 로고
    • http://www.neurogen.com/index.php?option=com_content&view= article&id=47&Itemid=2&phpMyAdmin=34a2390c0eecf801a871-d79668695b95.
  • 146
    • 84876077445 scopus 로고    scopus 로고
    • http://www.jti.co.jp/investors/others/12g3_2/pdf/20110831_01.pdf.
  • 147
    • 84876090108 scopus 로고    scopus 로고
    • http://clinicaltrials.gov/ct2/show/NCT00969787?term=DWP-05195&rank=3.
  • 148
    • 84876074235 scopus 로고    scopus 로고
    • http://clinicaltrials.gov/ct2/show/NCT01557010?term=DWP-05195&rank=2.
  • 149
    • 84876088570 scopus 로고    scopus 로고
    • http://www.astrazeneca.com/_mshost3690701/content/resources/-media/investors/10809118/AZN-Q2-2010-Pipeline-Summary.pdf.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.